Sign inJoin waitlistJoin the waitlist

YH

Yariv Houvras

Medical Oncology

Credentials: · · · ·

History

Hematology and Medical Oncology
Mass General Brigham
2004–2008
Internal Medicine
Massachusetts General Hospital
2001–2003
Icahn School of Medicine at Mount Sinai
1997–2001

Research

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
Cell · 2012 · 660 citations
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1
Nature · 1997 · 468 citations
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset
Nature · 2011 · 438 citations

Wolfram Goessling
7 papers
Leonard Zon
5 papers
Kimberley Evason
4 papers
Juan Mosquera
3 papers
Katie Lee
3 papers · 1 as a resident
Raul Martinez-McFaline
3 papers · 1 as a resident
Sahar Nissim
3 papers
Shaham Beg
3 papers · 3 as a resident
Theresa Scognamiglio
3 papers
Christine Lian
2 papers · 1 as a fellow
CB
Courtney Balgobin
2 papers · 1 as a resident
DY
Dean Yimlamai
2 papers

Grants

Building Personalized Avatars of Human Cancer to Predict Response to Therapy
National Cancer Institute · R21
Contact PI · $405.5K · Weill Medical Coll of Cornell Univ
2015–2017
Hematopoietic Stem Cell Development in Zebrafish
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $665.6K · Weill Medical Coll of Cornell Univ
2006–2011

Clinical trials

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Study director · Recruiting · Phase 1, Phase 2
Tubulis GmbH
2024–2028
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Study director · Recruiting · Phase 1, Phase 2
Tubulis GmbH
2024–2027